Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017

DUBLIN, June 18, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/4b8vj2/injectable_drug) has announced the addition of the "Injectable Drug Delivery Market by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Global Forecasts to 2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )


The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The global injectable drug delivery formulations technologies market was the largest segment in this market. This is due to surge of biologics and development of nanotechnologies. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self-injection devices.

The growth of the injectable drug delivery technologies market is primarily triggered by product life cycle management, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes at global level and improving patient compliance. The evolving opportunities in this market for manufacturers include development of biosimilars in pharmaceutical markets and focus of pharmaceutical manufacturers towards emerging markets such as, India, and China. However, factors such as needle-stick injuries and infections, development of alternate delivery methods and product recalls are restraining the growth of the market.

Key Topics Covered:

1 Introduction

1.1 Key Take-Aways

2 Executive Summary

3 Market Overview

4 Global Injectable Drug Delivery Devices Technologies Market

5 Global Injectable Drug Delivery Formulation Technologies Market

6 Global Injectable Drug Delivery Technologies Market, By Therapeutic Applications

7 Geographic Analysis

8 Competitive Landscape

9 Company Profiles

Companies Mentioned

- Alkermes, Inc.
- Antares Pharma, Inc.
- Baxter International, Inc.
- Becton, Dickinson And Company
- Bespak Europe, Ltd.
- Crossject
- Elcam Medical
- Eli Lilly And Company
- Gerresheimer Ag
- Haselmeier Gmbh
- Injex Pharma Gmbh
- Novo Nordisk A/S
- Owen Mumford, Ltd.
- Sanofi
- Schott Ag
- Shl Group
- Terumo Corporation
- Unilife Corporation
- Vetter Pharma-Fertigung Gmbh & Co. Kg
- West Pharmaceutical Services, Inc.
- Ypsomed Holding Ag
- Zogenix, Inc.

For more information visit http://www.researchandmarkets.com/research/4b8vj2/injectable_drug

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Drug Delivery

SOURCE Research and Markets